Gyre Therapeutics

GYRENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$841.899 M

$7.55 +5.15%

Close of 18 Sept 2026

Revenue

$116.6M

#2455 by revenue

Earnings

$9.88M

#2043 by earnings

Shares outstanding

111,509,849

Latest filing cover page

P/E ratio

85.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#170Wave Life SciencesWVE$857.2M
#171ArdelyxARDX$852.2M
#172Gyre TherapeuticsGYRE$841.9M
#173GeronGERN$835.2M
#174Aclaris TherapeuticsACRS$809.6M

What if Gyre Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$272,509.19

Per share 36,094× higher

Bitcoin $1.64T

$14,671.60

Per share 1,943× higher

Nvidia $5.36T

$48,037.97

Per share 6,363× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Gyre Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.